Centene Co. (NYSE:CNC) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC lessened its stake in shares of Centene Co. (NYSE:CNC) by 2.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 90,628 shares of the company’s stock after selling 2,671 shares during the period. Yousif Capital Management LLC’s holdings in Centene were worth $6,726,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Operose Advisors LLC acquired a new stake in Centene in the 3rd quarter valued at about $25,000. Turtle Creek Wealth Advisors LLC purchased a new stake in shares of Centene in the 4th quarter valued at approximately $25,000. OFI Invest Asset Management purchased a new stake in shares of Centene in the 3rd quarter valued at approximately $26,000. Riggs Asset Managment Co. Inc. purchased a new stake in shares of Centene in the 4th quarter valued at approximately $32,000. Finally, Headinvest LLC purchased a new stake in shares of Centene in the 3rd quarter valued at approximately $35,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Insider Buying and Selling

In related news, President Kenneth J. Fasola sold 12,000 shares of the business’s stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $75.07, for a total transaction of $900,840.00. Following the sale, the president now owns 235,365 shares of the company’s stock, valued at $17,668,850.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Lori Jean Robinson sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $77.41, for a total value of $774,100.00. Following the completion of the transaction, the director now owns 11,455 shares of the company’s stock, valued at $886,731.55. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, President Kenneth J. Fasola sold 12,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $75.07, for a total transaction of $900,840.00. Following the completion of the transaction, the president now directly owns 235,365 shares of the company’s stock, valued at approximately $17,668,850.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

Centene Trading Up 0.5 %

Shares of Centene stock opened at $76.19 on Thursday. Centene Co. has a 1 year low of $60.83 and a 1 year high of $81.42. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.11 and a current ratio of 1.11. The company has a market capitalization of $40.75 billion, a P/E ratio of 15.52, a PEG ratio of 0.94 and a beta of 0.38. The company’s fifty day moving average is $76.47 and its two-hundred day moving average is $74.75.

Centene (NYSE:CNC) last issued its earnings results on Tuesday, February 6th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. The business had revenue of $39.46 billion for the quarter, compared to the consensus estimate of $36.16 billion. Centene had a net margin of 1.75% and a return on equity of 14.26%. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.86 earnings per share. Analysts forecast that Centene Co. will post 6.75 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $90.00 price target on shares of Centene in a research note on Thursday, April 4th. Stephens reaffirmed an “equal weight” rating and set a $85.00 price objective (down previously from $92.00) on shares of Centene in a research report on Thursday, March 21st. Barclays initiated coverage on shares of Centene in a research report on Wednesday, March 6th. They set an “overweight” rating and a $101.00 price objective for the company. StockNews.com cut shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Thursday, March 28th. Finally, Wells Fargo & Company raised their price target on shares of Centene from $89.00 to $93.00 and gave the company an “overweight” rating in a research report on Monday, April 15th. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, Centene presently has a consensus rating of “Moderate Buy” and a consensus target price of $85.38.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.